Return
Letter: Calendar Era or Antiviral Choice—What Explains the Survival Benefit of Tenofovir Disoproxil Fumarate After Hepatocellular Carcinoma Resection?
L
C
DOI:10.1111/apt.70913.png)
Abstract
En
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
A
IF:
6.7
Papers:
422
Citations:
0
